Consolidated Statement Of Profit Or Loss

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7315150

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Consolidated statement of profit or loss
Statement of profit or loss
Revenue
1,111,367,000,000 JPY
1,259,726,000,000 JPY
Cost of sales
413,306,000,000 JPY
476,251,000,000 JPY
Gross profit
698,061,000,000 JPY
783,475,000,000 JPY
Selling, general and administrative expenses
112,580,000,000 JPY
100,477,000,000 JPY
Other expenses
JPY
2,134,000,000 JPY
Operating profit (loss)
439,174,000,000 JPY
533,309,000,000 JPY
Finance costs
27,000,000 JPY
61,000,000 JPY
Profit (loss) before tax
443,821,000,000 JPY
531,166,000,000 JPY
Income tax expense
118,349,000,000 JPY
156,737,000,000 JPY
Profit (loss)
325,472,000,000 JPY
325,472,000,000 JPY
JPY
JPY
325,472,000,000 JPY
JPY
JPY
JPY
JPY
374,429,000,000 JPY
374,429,000,000 JPY
374,429,000,000 JPY
Profit (loss) attributable to
Owners of parent
325,472,000,000 JPY
374,429,000,000 JPY
Earnings (loss) per share
Basic earnings (loss) per share
197.83
227.64
Diluted earnings (loss) per share
197.80
227.57

Talk to a Data Expert

Have a question? We'll get back to you promptly.